Concepedia

Author

Yasuhide Ikenaka

Nara Medical University

Also Known As

Y IKENAKA, Y Ikenaka, Y. Ikenaka, YASUHIDE IKENAKA, Yasuhide Ikenaka

62

Publications

3.4K

Citations

29

H-Index

78

Concepts

All Affiliations

Nara Medical UniversityKagawa University
YI

About

Yasuhide Ikenaka is an author at Nara Medical University specializing in medicine, pharmacology, and liver physiology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

21

23

1.9K

2

Health Sciences

9

9

860

3

Cell Biology

6

6

552

4

Biochemistry

3

3

120

5

Allergy

1

1

31

Yasuhide Ikenaka

×

43

Publications

3.3K

Citations

29

H-Index

YearCitations

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats

Hitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii,

Hepatology

2001

382

Tissue Inhibitor of Metalloproteinases–1 Promotes Liver Fibrosis Development in A Transgenic Mouse Model

Hitoshi Yoshiji, Shigeki Kuriyama, Yoji Miyamoto,

Hepatology

2000

251

Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse

Hitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii,

Hepatology

2002

216

The angiotensin-I-converting enzyme inhibitor perindopril suppresses tumor growth and angiogenesis: possible role of the vascular endothelial growth factor.

Hitoshi Yoshiji, Shinichi Kuriyama, Mitsuhiro Kawata,

PubMed

2001

210

Protein kinase C lies on the signaling pathway for vascular endothelial growth factor-mediated tumor development and angiogenesis.

Hitoshi Yoshiji, Shigeki Kuriyama, D. Kirk Ways,

PubMed

1999

183

Imatinib mesylate (STI-571) attenuates liver fibrosis development in rats

Hitoshi Yoshiji, Ryuichi Noguchi, Shigeki Kuriyama,

American Journal of Physiology-Gastrointestinal and Liver Physiology

2004

146

Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma

Hitoshi Yoshiji, Shigeki Kuriyama, Junichi Yoshii,

Hepatology

2002

146

Leptin‐mediated neovascularization is a prerequisite for progression of nonalcoholic steatohepatitis in rats†

Mitsuteru Kitade, Hitoshi Yoshiji, Hideyuki Kojima,

Hepatology

2006

143

Dipeptidyl peptidase-4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats

Kosuke Kaji, Hitoshi Yoshiji, Yasuhide Ikenaka,

Journal of Gastroenterology

2013

130

Tissue inhibitor of metalloproteinases‐1 (TIMP‐1) inhibits tumor growth and angiogenesis in the TIMP‐1 transgenic mouse model

Yasuhide Ikenaka, Hitoshi Yoshiji, Shigeki Kuriyama,

International Journal of Cancer

2003

109

Page 1